Humacyte, Inc. (HUMAW) NASDAQ
0.09
+0.0042(+4.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.09
+0.0042(+4.63%)
Currency In USD
| Market Cap | 598.32M |
| Enterprise Value | 569.92M |
| P/E Ratio | -4.97 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 18.83 |
| Price/Book Ratio | -38.65 |
| Enterprise/Revenue | 20 |
| Enterprise/EBITDA | -9.29 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -4.2 |
| Operating Margin | -11.98 |
| Return On Assets | -0.4 |
| Return On Equity | 8.54 |
| Revenue | 0 |
| Revenue/Share | 0.06 |
| Gross Profit | -7.19M |
| EBITDA | -132.23M |
| Net Income | -148.7M |
| Diluted EPS | -1.26 |
| Total Cash | 19.49M |
| Total Cash/Share | 0.12 |
| Total Debt | 29.83M |
| Total Debt/Equity | -6.28 |
| Current Ratio | 1.62 |
| Book Value Per Share | -0.03 |
| 52-Week Change | -90.01 |
| 52-Week High | 0.23 |
| 52-Week Low | 0.09 |
| Moving Average 50 Days | 0.12 |
| Moving Average 200 Days | 0.27 |
| Average Volume | 20,740.48 |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |